ALGS vs LC · rev $3.6M vs P/E 28, $1.43B cap
Aligos Therapeutics Inc (ALGS) versus LendingClub Corp (LC) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
LendingClub Corp (LC) is a banks - regional company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
LC does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. LC currently screens at market cap $1.43B and trailing P/E 28.4.
Not investment advice. Open the ALGS and LC stock pages for the full models.
Not investment advice.